Seoul
Venable attorney Jeremiah J. Kelly will present “Biopharma and Device Procurement and Entry Strategies for the U.S. Market and Regulatory Compliance with the U.S. FDA,” at Global Bio & Pharma Plaza 2023 hosted by the Korea Trade Investment Promotion Agency and Korea Pharmaceutical Traders Association, on September 14 in Seoul, South Korea.
The panel will provide access strategies to the global market, introduction of registration systems, support programs for global investments including M&A, and cooperation strategy of global corporations. On-site opportunities will include contract signing ceremonies between buyers, as well as overall access to 100 Korean bio-pharma companies.
For more information and to register, please click here.